The Methodist Hospital System

8 results found.

Aortic Aneurysm, or Aortic Disease Clinical Trial using clevidipine.

The Methodist Hospital System - Recruiting 18 years or older.
- A Safety and Efficacy Study of Blood Pressure Control in Acute Aortic Emergencies - A Pilot Study (PROMPT).
clevidipine.

Central Nervous System (CNS) Metastases, or Brain Metastases Clinical Trial using Topotecan; Temozolomide

The Methodist Hospital System - Recruiting 18 years to 79 years.
- Phase II Trial of Chemotherapy With Temozolomide in Combination With Topotecan for Central Nervous System (CNS) Metastasis of Solid Tumors.
Topotecan; Temozolomide

Ventricular Tachycardia, or Atrial Fibrillation Clinical Trial using Ethanol; Ablation

The Methodist Hospital System - Recruiting 18 years to 85 years.
- Vein of Marshall Ethanol Infusion for Persistent Atrial Fibrillation.
Ethanol; Ablation

Breast Neoplasms, or Breast Cancer Clinical Trial using Taxane; Taxotere; Abraxane; Ixabepilone

The Methodist Hospital System - Recruiting 18 years or older.
- Phase II Study of The Efficacy And Safety of Chloroquine (C) in CombinAtion With Taxane or Taxane-like (T) Chemo Agents in The Treatment of Patients With Advanced or Metastatic Breast Cancer Who Have Failed Anthracycline Chemo Base Therapy..
Taxane; Taxotere; Abraxane; Ixabepilone

Breast Cancer Clinical Trial using Anthracycline based chemotherapy; taxane-based chemotherapy

The Methodist Hospital System - Recruiting 18 years or older.
- Prospective Study To Validate The Predictive Value Of Mammostrat Score, DDR Score And TLE3 Gene When A Taxane-Based Chemo Agents Or Anthracycline-Based Chemo Agent Is Used In The Neo-Adjuvant Setting.
Anthracycline based chemotherapy; taxane-based chemotherapy

Breast Cancer, or Triple Negative Breast Cancer Clinical Trial using Everolimus

The Methodist Hospital System - Recruiting 18 years or older.
- Neoadjuvant Phase II Study Of Everolimus Plus Cisplatin In Triple Negative Breast Cancer Patients With Residual Disease After Standard Chemotherapy.
Everolimus

Breast Cancer Clinical Trial using Trastuzumab Emtansine; Trastuzumab; Lapatinib; Abraxane; Paclitaxel

The Methodist Hospital System - Recruiting 18 years or older.
- Randomized Open Label Phase II Trial Of Neoadjuvant Trastuzumab Emtansine (Te) In Combination With Lapatinib (L) Follow by Abraxane (A) Compared With Trastuzumab Plus Lapatinib Follow by Paclitaxel In Her 2 Neu Over-Expressed Breast Cancer Patients (TEAL Trial).
Trastuzumab Emtansine; Trastuzumab; Lapatinib; Abraxane; Paclitaxel

Metastatic Breast Cancer Clinical Trial using TDM1; Lapatinib; Abraxane

The Methodist Hospital System - Recruiting 18 years or older.
- Phase Ib Trial of Trastuzumab Emtansine In Combination With Lapatinib Plus Abraxane In Metastatic Her 2 Neu Over-Expressed Breast Cancer Patients.
TDM1; Lapatinib; Abraxane